Double Attack on Cancer

New research at the Institute may offer a sliver of hope for treating “triple-negative” breast cancer. “Triple-negative” refers to the fact that the breast cancer cells are missing the three different receptors targeted by the currently available drugs, for instance Herceptin and steroid hormone blockers. This type of cancer also tends to be fairly aggressive, and the risk of early recurrence is higher than for other types of breast cancer.

Triple-negative breast cancer cells do have other receptors – particularly EGFR, a growth factor receptor that would seem to be a good target for anticancer antibodies. The problem is that previously tested agents that block EGFR have been found to be ineffective in treating the cancer.

The Weizmann team’s innovation was to go after the EGF receptor with two different antibodies that bound to the receptor from different sides. More than just a one-two punch, the double attack worked better than expected. The scientists think that the weight of the two antibodies on one receptor may not only block it, but cause it to collapse back into the tumor cell.

4.0.4
Breast cancer cell. Image: NCI

All of this, we should point out, worked in mice. Any human studies are well in the future. On the other hand, if the study results are born out, the double-attack approach could prove fruitful for other types of cancer, as well.

Two other news items that went online today:

Researchers discover a star’s “mini-explosion” taking place just a month before an all-out supernova explosion.

A biological device made of DNA inserted into a bacterial cell works like a tiny diagnostic computer.

More like this

What is a breakthrough in cancer research? It is a new piece of a puzzle made up of a million pieces. It may, however, be a piece that allows a picture to start emerging – one that lets us see the shape of the next piece needed to fill in more of the puzzle, or start making changes to rearrange the…
My short post on breast-feeding from a few days ago (inspired by this article by Hanna Rosin) has inspired a lot of dissenting email. Since comments are still disabled - I hope to have them back soon, though - I want to post a selection of the criticism. Just to reiterate and clarify: I don't want…
"Personalized medicine." You've probably heard the term. It's a bit of a buzzword these days and refers to a vision of future medicine in which therapies are much more tightly tailored to individual patients than they currently are. That's not to say that as physicians we haven't practiced…
About a year ago, I addressed what might seem to the average reader to be a very simple, albeit clichéd question: If we can put a man on the moon, why can't we cure cancer? As I pointed out at the time, it's a question that I sometimes even ask myself, particularly given that cancer has touched my…

This article has helped me research new antibodies to prevent breast cancer. Another antibody that is well used us TIMP-1. High levels of TIMP1 have been found in several types of cancers i.e. breast cancer, where the augment has been related to an adverse patient prognosis.

As a result, TIMP1 can provide assistance to identify patients with particularly hostile diseases for adjuvant treatment. Human antibodies that bind to TIMP1 can be used as reagents to diagnose and treat disorders in which TIMP1 is elevated. For example, liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon cancer, lung cancer, and idiopathic pulmonary fibrosis can be treated from the TIMP-1 antibody.

Biorbyt are one of the worlds leading antibodies suppliers and helps scientists with this research. It would be interesting if scienceblogs.com does some promo for them to get more recognition.

http://www.biorbyt.com/timp-1-antibody

By TIMP1 antibody (not verified) on 08 Feb 2013 #permalink

Good day! Would you mind if I share your blog with my facebook group? There's a lot of people that I think would really appreciate your content. Please let me know. Thanks

By breast actives… (not verified) on 02 May 2013 #permalink

Absolutely. In fact, thanks for sharing it.

Greetings from Ohio! I am bored to tears at work so I decided to browse your blog on my iphone during lunch break. I really like the knowledge you provide here and can't wait to take a look when I get home. I'm surprised at how fast your blog loaded on my phone .. I am not even using WIFI, just 3G .. Anyhow, awesome site!

By 行動電源 (not verified) on 06 Jul 2013 #permalink